Marc Semigran

CIK 1691494 · Chief Development Officer · last filed 2024-12-27

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$294.1K

Companies

3

Total Filings

16

Lifetime Open-Market Net

-$3.56M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EWTX Chief Development Officer 8,445 $34.83 $294.1K -$881.9K 4 2024-12-27
Renovacor, Inc. (RCOR.WS) Delisted Chief Medical Officer 52,651 $0.07 $3.7K $0 3 2022-01-26
MyoKardia, Inc. (MYOK) Delisted Chief Medical Officer 1,110 -$2.68M 8 2019-02-12

Recent Filings · Page 2 of 2

16 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-01-03 MyoKardia, Inc. (MYOK) Delisted Exer (M) +1,325 $0 EDGAR
2018-12-20 MyoKardia, Inc. (MYOK) Delisted Grant (A) +302 $12.7K EDGAR
2018-09-06 MyoKardia, Inc. (MYOK) Delisted Mixed -$1.96M EDGAR
2018-06-29 MyoKardia, Inc. (MYOK) Delisted Grant (A) $0 EDGAR
2018-01-18 MyoKardia, Inc. (MYOK) Delisted Grant (A) $0 EDGAR
2016-12-05 MyoKardia, Inc. (MYOK) Delisted Grant (A) $0 EDGAR
Showing 1116 of 16
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.